Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.35
Nov. 12, 2025 16:00:01- Change -0.0059 (-1.64712%)
- Volume 734,840
- Today's Open 0.3532
- Previous Close 0.3582
- Today's High 0.361
- Today's Low 0.3473
- 52 Week High 4.3
- 52 Week Low 0.281